Philadelphia-negative acute lymphoblastic leukemia developing in a CML patient in imatinib mesylate-induced complete cytogenetic remission

被引：0
|
作者：
S Cherrier-De Wilde
K Rack
P Vannuffel
A Delannoy
A Hagemeijer
机构：
[1] Hematology Unit,Department of Human Genetics
[2] Hôpital de Jolimont,undefined
[3] Haine-Saint-Paul,undefined
[4] Institute of Pathology and Genetics,undefined
[5] University of Leuven,undefined
来源：
Leukemia | 2003年 / 17卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2046 / 2048
页数：2
相关论文
共 50 条
  • [1] Philadelphia-negative acute lymphoblastic leukemia developing in a CML patient in imatinib mesylate-induced complete cytogenetic remission
    Cherrier-De Wilde, S
    Rack, K
    Vannuffel, P
    Delannoy, A
    Hagemeijer, A
    LEUKEMIA, 2003, 17 (10) : 2046 - 2048
  • [2] Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission
    Marks, David I.
    Perez, Waleska S.
    He, Wensheng
    Zhang, Mei-Jie
    Bishop, Michael R.
    Bolwell, Brian J.
    Bredeson, Christopher N.
    Copelan, Edward A.
    Gale, Robert Peter
    Gupta, Vikas
    Hale, Gregory A.
    Isola, Luis M.
    Jakubowski, Ann A.
    Keating, Armand
    Klumpp, Thomas R.
    Lazarus, Hillard M.
    Liesveld, Jane L.
    Maziarz, Richard T.
    McCarthy, Philip L.
    Sabloff, Mitchell
    Schiller, Gary
    Sierra, Jorge
    Tallman, Martin S.
    Waller, Edmund K.
    Wiernik, Peter H.
    Weisdorf, Daniel J.
    BLOOD, 2008, 112 (02) : 426 - 434
  • [3] Myelodysplastic features developing in Philadelphia-negative cells during imatinib mesylate therapy for CML:: report of a new case
    Mozziconacci, MJ
    Caillères, S
    Maurice, C
    Vey, N
    Sainty, D
    Blaise, D
    Lafage-Pochitaloff, M
    LEUKEMIA, 2003, 17 (09) : 1901 - 1902
  • [4] Imatinib mesylate-induced molecular remission of Philadelphia chromosome-positive myelodysplastic syndrome
    Drummond, MW
    Lush, CJ
    Vickers, MA
    Reid, FM
    Kaeda, J
    Holyoake, T
    LEUKEMIA, 2003, 17 (02) : 463 - 465
  • [5] Imatinib mesylate-induced molecular remission of Philadelphia chromosome-positive myelodysplastic syndrome
    M W Drummond
    C J Lush
    M A Vickers
    F M Reid
    J Kaeda
    T L Holyoake
    Leukemia, 2003, 17 : 463 - 465
  • [6] Imatinib mesylate-induced pseudoporphyria in a patient with chronic myeloid leukemia
    Batrani, Meenakshi
    Salhotra, Manish
    Kubba, Asha
    Agrawal, Manjul
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2016, 82 (06): : 727 - 729
  • [7] Philadelphia-negative acute lymphoblastic leukemia in a chronic myeloid leukemia patient receiving dasatinib
    Santos, Fabio P. S.
    Rodrigues, Morgani
    Bley Do Nascimento, Claudia Mac-Donald
    Kerbauy, Fabio R.
    Feitosa Ribeiro, Andreza Alice
    Kutner, Jose Mauro
    Hamerschlak, Nelson
    CYTOTHERAPY, 2010, 12 (01) : 113 - 115
  • [8] Emergence of Ph negative clones in chronic myeloid leukemia (CML) patients in complete cytogenetic remission after therapy with imatinib mesylate (STI)
    Gozzetti, A
    Tozzuoli, D
    Crupi, R
    Gentili, S
    Bocchia, M
    Raspadori, D
    Lauria, F
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2003, 71 (04) : 313 - 314
  • [9] Long-term molecular remission after conventional chemotherapy in a patient with Philadelphia-negative acute lymphoblastic leukemia
    Ladetto, M
    Corradini, P
    Astolfi, M
    Campana, S
    Tarella, C
    Pileri, A
    HAEMATOLOGICA, 1996, 81 (02) : 159 - 161
  • [10] Imatinib mesylate (Gleevec) induced remission in Philadelphia chromosome-negative BCR-ABL negative atypical chronic myelogenous leukemia (CML).
    Seftel, MD
    Horsman, DE
    Berry, B
    Parslow, M
    Pewarchuk, WJ
    Nantel, SH
    BLOOD, 2002, 100 (11) : 326B - 327B
12345